The peptide has demonstrated neuroprotective properties and effects on neurotransmitter systems in various research models
Reddy PH, Yin X, Manczak M, Kumar S, Jangampalli Adi P, Vijayan M, Reddy AP
Ito TK, et al
Inflammasome activation in infected macrophages drives COVID-19 pathology
Suzhou-based Innovent Biologics saw its obesity drug, Mazdutide, approved by Chinese regulators last yearand according to a 2025 report released by LEK Consulting, China has more than 60 obesity drug candidates under development that are set to compete with those produced in the United States
International journal of physiology, pathophysiology and pharmacology , 10 (3), 132138